News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
123,725 Results
Type
Article (4603)
Company Profile (18)
Press Release (119104)
Section
Business (36874)
Career Advice (112)
Deals (5835)
Drug Delivery (6)
Drug Development (7285)
Employer Resources (12)
FDA (3328)
Job Trends (2415)
News (54021)
Policy (4132)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (397)
Adcomms (6)
Allergies (9)
Alliances (11503)
ALS (6)
Alzheimer's disease (372)
Antibody-drug conjugate (ADC) (6)
Approvals (3332)
Artificial intelligence (88)
Autoimmune disease (2)
Automation (4)
Bankruptcy (47)
Best Places to Work (2056)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (14)
Brain cancer (5)
Breast cancer (72)
Cancer (502)
Cardiovascular disease (29)
Career advice (103)
Career pathing (1)
CAR-T (17)
Cell therapy (38)
Cervical cancer (7)
Clinical research (5813)
Collaboration (185)
Compensation (16)
Complete response letters (1)
COVID-19 (502)
C-suite (39)
Cystic fibrosis (9)
Data (354)
Decentralized trials (1)
Depression (11)
Diabetes (17)
Diagnostics (5841)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (16)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (14761)
Employer branding (2)
Employer resources (12)
Events (20637)
Executive appointments (119)
FDA (3539)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (132)
Gene editing (3)
Generative AI (8)
Gene therapy (17)
GLP-1 (45)
Government (654)
Guidances (12)
Healthcare (3401)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (7)
Indications (4)
Infectious disease (535)
Inflammatory bowel disease (12)
Influenza (14)
Intellectual property (9)
Interviews (13)
IPO (2263)
IRA (1)
Job creations (432)
Job search strategy (98)
Kidney cancer (8)
Labor market (1)
Layoffs (28)
Leadership (1)
Legal (561)
Liver cancer (11)
Lung cancer (73)
Lymphoma (39)
Machine learning (1)
Management (3)
Manufacturing (45)
MASH (6)
Medical device (2799)
Medtech (2800)
Mergers & acquisitions (3673)
Metabolic disorders (40)
Multiple sclerosis (21)
NASH (3)
Neurodegenerative disease (12)
Neuropsychiatric disorders (5)
Neuroscience (449)
NextGen: Class of 2025 (806)
Non-profit (611)
Northern California (553)
Now hiring (2)
Obesity (16)
Opinion (11)
Ovarian cancer (14)
Pain (6)
Pancreatic cancer (12)
Parkinson's disease (19)
Partnered (3)
Patents (24)
Patient recruitment (12)
Peanut (4)
People (9297)
Pharmaceutical (1)
Phase I (1802)
Phase II (2541)
Phase III (2118)
Pipeline (178)
Policy (2)
Postmarket research (242)
Preclinical (762)
Press Release (11)
Prostate cancer (38)
Psychedelics (27)
Radiopharmaceuticals (129)
Rare diseases (38)
Real estate (911)
Recruiting (5)
Regulatory (3254)
Reports (10)
Research institute (455)
Resumes & cover letters (15)
Rett syndrome (1)
RSV (1)
Schizophrenia (3)
Series A (17)
Series B (13)
Service/supplier (2)
Sickle cell disease (3)
Southern California (446)
Special edition (1)
Spinal muscular atrophy (17)
Sponsored (6)
Startups (647)
Stomach cancer (2)
Supply chain (6)
The Weekly (6)
United States (4174)
Vaccines (45)
Venture capitalists (6)
Weight loss (5)
Women's health (7)
Date
Today (39)
Last 7 days (139)
Last 30 days (462)
Last 365 days (6303)
2025 (2058)
2024 (6692)
2023 (7868)
2022 (11763)
2021 (11000)
2020 (10293)
2019 (7125)
2018 (5565)
2017 (5949)
2016 (6035)
2015 (7004)
2014 (5281)
2013 (4530)
2012 (4929)
2011 (5095)
2010 (4463)
Location
Africa (136)
Alabama (6)
Alaska (1)
Arizona (60)
Arkansas (2)
Asia (5766)
Australia (1360)
California (1198)
Canada (307)
China (45)
Colorado (65)
Connecticut (73)
Delaware (22)
Europe (16173)
Florida (173)
Georgia (54)
Idaho (4)
Illinois (109)
India (4)
Indiana (45)
Iowa (4)
Japan (26)
Kansas (13)
Kentucky (5)
Louisiana (1)
Maine (20)
Maryland (117)
Massachusetts (613)
Michigan (68)
Minnesota (74)
Missouri (34)
Montana (4)
Nebraska (9)
Nevada (5)
New Hampshire (19)
New Jersey (219)
New Mexico (17)
New York (359)
North Carolina (210)
North Dakota (6)
Northern California (553)
Ohio (34)
Oklahoma (2)
Oregon (9)
Pennsylvania (140)
Rhode Island (5)
South America (161)
South Carolina (4)
Southern California (446)
Tennessee (31)
Texas (191)
Utah (87)
Virginia (37)
Washington D.C. (6)
Washington State (107)
Wisconsin (30)
123,725 Results for "pts diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phanes Therapeutics Announces First Patient Dosed in Clinical Study of Peluntamig (PT217) in Combination with Chemotherapy
February 19, 2025
·
2 min read
Press Releases
Phanes Therapeutics’ PT217 granted Fast Track Designation by the FDA for NEPC
December 5, 2024
·
2 min read
Press Releases
BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA
February 25, 2025
·
1 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Biotech Beach
Phanes Therapeutics’ PT217 granted Fast Track Designation by the FDA
Phanes Therapeutics, Inc. (Phanes) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PT217 for the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression following platinum chemotherapy with or without a checkpoint inhibitor.
April 8, 2024
·
2 min read
Press Releases
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
April 25, 2025
·
6 min read
Press Releases
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
·
3 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Drug Development
Phanes Therapeutics Announces First Patient Dosed in Clinical Study of PT886 in Combination with KEYTRUDA® (pembrolizumab)
October 8, 2024
·
2 min read
Press Releases
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
April 14, 2025
·
4 min read
1 of 12,373
Next
